Reference
Ou SHI, et al. Radiation necrosis presenting as pseudoprogression (PsP) during alectinib treatment of previously radiated brain metastases in ALK-positive NSCLC: Implications for disease assessment and management. Lung Cancer 88: 355-359, No. 3, Jun 2015. Available from: URL: http://doi.org/10.1016/j.lungcan.2015.03.022 - USA
Rights and permissions
About this article
Cite this article
Alectinib. Reactions Weekly 1582, 25 (2015). https://doi.org/10.1007/s40278-015-12020-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-12020-9